Aperçu des produits pour anti-FLT4 (FLT4) Anticorps

Full name:
anti-Fms-Related Tyrosine Kinase 4 Anticorps (FLT4)
Chez www.anticorps-enligne.fr sont 249 Fms-Related Tyrosine Kinase 4 (FLT4) Anticorps de 35 de différents fournisseurs disponibles. De plus, nous expédions FLT4 Kits (47) et FLT4 Protéines (36) et beaucoup plus de produits pour cette protéine. Un total de 340 FLT4 produits sont actuellement listés.
Synonymes:
6130401C07, AI323512, cb1059, Chy, Flk-1, Flk1, Flt-4, FLT41, Krd-1, LMPH1A, Ly73, PCL, sVEGFR-2, VEGFR-2, VEGFR-3, VEGFR2, Vegfr3

Réactivités les plus populaires pour anti-FLT4 (FLT4) Anticorps

Sélectionnez vos espèces et l'application

anti-Mouse (Murine) FLT4 Anticorps:

anti-Human FLT4 Anticorps:

anti-Rat (Rattus) FLT4 Anticorps:

Tous anti-FLT4 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-FLT4 Anticorps mieux référencés

  1. Human Monoclonal FLT4 Primary Antibody pour FACS - ABIN4896919 : Shawber, Funahashi, Francisco, Vorontchikhina, Kitamura, Stowell, Borisenko, Feirt, Podgrabinska, Shiraishi, Chawengsaksophak, Rossant, Accili, Skobe, Kitajewski: Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. dans The Journal of clinical investigation 2007 (PubMed)
    Show all 5 references for 4896919

  2. Human Monoclonal FLT4 Primary Antibody pour FACS - ABIN4896918 : Roorda, Ter Elst, Scherpen, Meeuwsen-de Boer, Kamps, de Bont: VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms. dans European journal of cancer (Oxford, England : 1990) 2010 (PubMed)
    Show all 5 references for 4896918

  3. Human Polyclonal FLT4 Primary Antibody pour WB - ABIN616061 : Paone, Galli, Gabellini, Lukashev, Starace, Gorlach, De Cesaris, Ziparo, Del Bufalo, Sitkovsky, Filippini, Riccioli: Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha. dans Neoplasia (New York, N.Y.) 2010 (PubMed)
    Show all 3 references for 616061

  4. Human Polyclonal FLT4 Primary Antibody pour ELISA, WB - ABIN1997515 : Shushanov, Bronstein, Adélaïde, Jussila, Tchipysheva, Jacquemier, Stavrovskaya, Birnbaum, Karamysheva: VEGFc and VEGFR3 expression in human thyroid pathologies. dans International journal of cancer. Journal international du cancer 2000 (PubMed)
    Show all 2 references for 1997515

  5. Human Monoclonal FLT4 Primary Antibody pour EIA, WB - ABIN115160 : Davids, Davids, Charlton, Ng, Chong, Laubscher, Dar, Hodge, Soong, Goh: Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. dans Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 (PubMed)
    Show all 2 references for 115160

  6. Human Monoclonal FLT4 Primary Antibody pour EIA, IHC (fro) - ABIN115161 : Jussila, Valtola, Partanen, Salven, Heikkilä, Matikainen, Renkonen, Kaipainen, Detmar, Tschachler, Alitalo, Alitalo: Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. dans Cancer research 1998 (PubMed)
    Show all 2 references for 115161

  7. Human Polyclonal FLT4 Primary Antibody pour IHC (fro), IHC (p) - ABIN115449 : Earnshaw, Halligan, Cooke, Heck, Liu: Topoisomerase II is a structural component of mitotic chromosome scaffolds. dans The Journal of cell biology 1985 (PubMed)
    Show all 2 references for 115449

  8. Mouse (Murine) Polyclonal FLT4 Primary Antibody pour FACS - ABIN4896915 : Imoukhuede, Popel: Expression of VEGF receptors on endothelial cells in mouse skeletal muscle. dans PLoS ONE 2012 (PubMed)

  9. Human Polyclonal FLT4 Primary Antibody pour IHC (p) - ABIN115450 : Dietrich, Onderka, Bock, Kruse, Vossmeyer, Stragies, Zahn, Cursiefen: Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. dans The American journal of pathology 2007 (PubMed)

Plus d’anticorps contre FLT4 partenaires d’interaction

Mouse (Murine) Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. The elevated soluble VEGFR-2 (Montrer KDR Anticorps) that was found in the aortas of apoE (Montrer APOE Anticorps)(-/-) mice with atherosclerosis binds to and diminishes the activity of VEGF-C (Montrer VEGFC Anticorps).

  2. Data show that Leishmania major infection initiates enhanced vascular endothelial growth factor-A (Montrer VEGFA Anticorps)/VEGFR-2 (Montrer KDR Anticorps) signaling and suggest that VEGFR-2 (Montrer KDR Anticorps)-dependent lymphangiogenesis is a mechanism that restricts tissue inflammation in leishmaniasis.

  3. VEGFR3 limits VEGFR2 (Montrer KDR Anticorps) expression and VEGF (Montrer VEGFA Anticorps)/VEGFR2 (Montrer KDR Anticorps) pathway activity in quiescent and angiogenic blood vascular endothelial cells, thereby preventing excessive vascular permeability.

  4. fetal mouse lung mesenchymal cells express Vegfr2 (Montrer KDR Anticorps) and respond to VEGF-A (Montrer VEGFA Anticorps) stimulation.

  5. Deletion of microRNA miR (Montrer MLXIP Anticorps)-150 increased the retinal pathological angiogenesis in high-fat-diet (HFD) induced type 2 diabetic mice, which was in part through vascular endothelial growth factor receptor 2 (VEGFR2 (Montrer KDR Anticorps)).

  6. findings demonstrated that a multi-component Chinese medicine DHI effectively increased blood flow recovery after tissue ischemia in diabetic mice by promoting angiogenesis and improving glucose tolerance through a concomitant activation of VEGF-A (Montrer VEGFA Anticorps)/VEGFR-2 (Montrer KDR Anticorps) and PPARdelta (Montrer PPARD Anticorps) signaling pathways

  7. Intronic Flk1 (Montrer KDR Anticorps) genetic enhancer element directs arterial-specific expression via RBPJ (Montrer RBPJ Anticorps)-mediated venous repression.

  8. Endothelial SCUBE2 may be a novel coreceptor for VEGFR2 and potentiate VEGF-induced signaling in adult angiogenesis.

  9. VEGFR2 (Montrer KDR Anticorps) signaling is necessary to maintain the integrity of the intestinal mucosal microvasculature during the postnatal period and lack of VEGFR2 (Montrer KDR Anticorps) signaling predisposes to NEC in neonatal mice.

  10. First-in-class selective PET tracers for imaging VEGFR-1 (Montrer FLT1 Anticorps) and VEGFR-2 (Montrer KDR Anticorps) were constructed and successfully validated in an orthotopic murine tumor model.

Human Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. There was a significant decrease in VEGFR3 expression in pulmonary arterial endothelial cells from pulmonary arterial hypertension patients.

  2. By treating LECs with VEGF (Montrer VEGFA Anticorps)-C156S and analyzing subsequent changes in gene expression, we identified several 'immediate early (Montrer JUN Anticorps)' transcription factors that showed a rapid transient upregulation VEGFR-3 stimulation. these results reveal an important and unanticipated role of HOXD10 (Montrer HOXD10 Anticorps) in the regulation of VEGFR-3 signaling in lymphatic endothelial cells, and in the control of lymphangiogenesis and permeability.

  3. The normalized methylation values for the VEGFR1 (Montrer FLT1 Anticorps), VEGFR2 (Montrer KDR Anticorps) and VEGFR3 promoters tended to be higher in the tumour cell lines than in normal tonsil samples, whereas amounts of VEGFR1 (Montrer FLT1 Anticorps), VEGFR2 (Montrer KDR Anticorps) and VEGFR3 messenger RNA were significantly higher

  4. These results indicate that VEGF-C (Montrer VEGFC Anticorps)-induced MSC (Montrer MSC Anticorps) osteogenesis is mediated through VEGFR2 (Montrer KDR Anticorps) and VEGFR3, and followed the activation of the ERK (Montrer EPHB2 Anticorps)/RUNX2 (Montrer RUNX2 Anticorps) signaling pathway.

  5. Assessment of VEGFR-2/VEGFR (Montrer KDR Anticorps)-3 on tumor samples might serve as a putative prognostic factor in renal cell carcinoma (Montrer MOK Anticorps) cases, identifying a subset of patients that may benefit from antiangiogenic treatments targeting VEGFR (Montrer KDR Anticorps) receptors.

  6. This study suggests that NRP1 (Montrer NELL1 Anticorps) expression and LVD are independent factors that are likely to predict the risk of LN metastasis in squamous cell carcinoma (SCC (Montrer CYP11A1 Anticorps))of the tongue, whereas the expression of VEGFC (Montrer VEGFC Anticorps), VEGFR3, CCR7 (Montrer CCR7 Anticorps), and SEMA3E (Montrer SEMA3E Anticorps) are nonindependent predictive factors

  7. Data indicate that vascular endothelial growth factor D (VEGF-D (Montrer Figf Anticorps)) was the best indicator of metastasis and vascular endothelial growth factors and receptor-3 (VEGFR-3) may help to determine the prognosis and management of colorectal cancer (CRC (Montrer CALR Anticorps)).

  8. The summarizes the structure and function features of pathway-related molecules of VEGFC (Montrer VEGFC Anticorps)/D-VEGFR3/NRP2 (Montrer NELL2 Anticorps) axis, stages of various tumors and their molecular mechanisms and significances in tuthe expression changes of these molecules in different anatomic organs or histopathologic types or development lymphatic metastasis.

  9. The most extensively accepted signaling pathways promoting lymphangiogenesis in tumors include the secreted lymphangiogenic proteins: VEGF-C (Montrer VEGFC Anticorps) and VEGF-D (Montrer Figf Anticorps), and their cognate receptor on lymphatic endothelium VEGF receptor (Montrer FLT1 Anticorps)-3 (VEGFR-3).

  10. MTA1 (Montrer MTA1 Anticorps) is up-regulated in CRC (Montrer CALR Anticorps); its expression is inversely associated with lymphatic metastases and the expression of VEGFC (Montrer VEGFC Anticorps), VEGFD (Montrer Figf Anticorps) and VEGFR3

Zebrafish Fms-Related Tyrosine Kinase 4 (FLT4) interaction partners

  1. miR (Montrer MYLIP Anticorps)-126a directs lymphatic endothelial cell sprouting and extension by interacting with Cxcl12a-mediated chemokine (Montrer CCL1 Anticorps) signaling and Vegfc (Montrer VEGFC Anticorps)-Flt4 signal axis.

  2. Ca(2 (Montrer CA2 Anticorps)+) oscillations depended upon VEGF receptor-2 (Vegfr2) and Vegfr3 in endothelial cells budding from the dorsal aorta (DA) and posterior cardinal (Montrer CARD8 Anticorps) vein, respectively.

  3. Experiments in mice and zebrafish demonstrate that changing levels of VEGFR3/Flt4 modulates aortic lumen diameter consistent with flow-dependent remodeling

  4. In the embryo, phenotypes driven by increased Vegfc (Montrer VEGFC Anticorps) are suppressed in the absence of Ccbe1 (Montrer CCBE1 Anticorps), and Vegfc (Montrer VEGFC Anticorps)-driven sprouting is enhanced by local Ccbe1 (Montrer CCBE1 Anticorps) overexpression. Moreover, Vegfc (Montrer VEGFC Anticorps)- and Vegfr3-dependent Erk (Montrer MAPK1 Anticorps) signaling is impaired in the absence of Ccbe1 (Montrer CCBE1 Anticorps).

  5. Flt4 plays an essential role in lymphangiogenesis [review]

  6. The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc (Montrer VEGFC Anticorps)/Vegfr3 signaling in zebrafish.

  7. Rspo1-Wnt-VegfC-Vegfr3 signaling plays a crucial role as an endothelial-autonomous permissive cue for developmental angiogenesis.

  8. flt4 signalling is suppressed by Dll4 (Montrer DLL4 Anticorps) in developing zebrafish intersegmental arteries.

FLT4 profil antigène

Antigen Summary

This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA.

Alternative names and synonyms associated with FLT4

  • FMS-like tyrosine kinase 4 (Flt4) anticorps
  • fms-related tyrosine kinase 4 (FLT4) anticorps
  • fms-related tyrosine kinase 4 (Flt4) anticorps
  • fms-related tyrosine kinase 4 (flt4) anticorps
  • kinase insert domain protein receptor (Kdr) anticorps
  • 6130401C07 anticorps
  • AI323512 anticorps
  • cb1059 anticorps
  • Chy anticorps
  • Flk-1 anticorps
  • Flk1 anticorps
  • Flt-4 anticorps
  • FLT41 anticorps
  • Krd-1 anticorps
  • LMPH1A anticorps
  • Ly73 anticorps
  • PCL anticorps
  • sVEGFR-2 anticorps
  • VEGFR-2 anticorps
  • VEGFR-3 anticorps
  • VEGFR2 anticorps
  • Vegfr3 anticorps

Protein level used designations for FLT4

chylous ascites , receptor protein tyrosine kinase , tyrosine-protein kinase receptor FLT4 , vascular endothelial growth factor receptor 3 , vascular endothelial growth factor receptor-3 , FLT-4 , VEGFR-3 , fms-like tyrosine kinase 4 , soluble VEGFR3 variant 1 , soluble VEGFR3 variant 2 , soluble VEGFR3 variant 3 , FMS-like tyrosine kinase 4 , tyrosine kinase VEGFR-3 , VEGFR3 , expando , receptor tyrosine kinase Flt4 , VEGF receptor-2 , fetal liver kinase 1 , kinase NYK , protein-tyrosine kinase receptor flk-1 , soluble vascular endothelial growth factor receptor 2 , vascular endothelial growth factor receptor 2 , vascular endothelial growth factor receptor- 2 , vascular endothelial growth factor receptor-2

GENE ID SPECIES
14257 Mus musculus
2324 Homo sapiens
114110 Rattus norvegicus
338031 Bos taurus
100008829 Oryctolagus cuniculus
395742 Gallus gallus
30121 Danio rerio
16542 Mus musculus
Fournisseurs de qualité sélectionnés pour anti-FLT4 (FLT4) Anticorps
Avez-vous cherché autre chose?